NCCN软组织肉瘤临床实践指南腹膜后软组织肉瘤部分解读  

Interpretation of soft tissue sarcoma (retroperitoneal sarcoma) section in NCCN clinical practice guideline

作　　者：闾晨涛[1] 陆维祺[2] Chen-tao;LU Wei-qi(Department of General Surgery,Shanghai Public Health Clinical Center,Zhongshan Hospital (South Branch),Fudan University,Shanghai 200083,China;Department of General Surgery,Zhongshan Hospital,Fudan University,Shanghai 200032,China)

机构地区：[1]上海市(复旦大学附属)公共卫生临床中心,复旦大学附属中山医院南院普通外科,上海200083 [2]复旦大学附属中山医院普通外科,上海200032

出　　处：《中国临床医学》2019年第3期321-325,316,共5页Chinese Journal of Clinical Medicine

摘　　要：软组织肉瘤是一类来源于结缔组织的少见恶性肿瘤。美国国立综合癌症网络(NCCN)持续更新并发布了关于软组织肉瘤的临床实践指南。本文对其中腹膜后软组织肉瘤(retroperitoneal sarcoma,RPS)部分进行解读,主要涉及RPS治疗流程中多学科诊疗模式(MDT)的应用及其分级分期、活检原则、手术原则、放疗治疗原则等内容,为其临床规范诊治提供参考。Soft tissue sarcoma is a rare malignant tumor originated from soft tissue. National Comprehensive Cancer Network (NCCN) has continually updated clinical practice guideline in soft tissue sarcoma. This article reviews the retroperitoneal soft tissue sarcoma section in the guideline, mainly involving the application of multi-discipline team (MDT) in the retroperitoneal sarcoma (RPS) treatment process, grading and staging, biopsy principles, surgical principles, radiotherapy principles, and other contents.

关 键 词：软组织肉瘤 腹膜后肉瘤 美国国立综合癌症网络 临床实践指南 

分 类 号：R730.262[医药卫生—肿瘤]